EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Jina Kim iD, Jason Chia-Hsien Cheng iD, Taek-Keun Nam iD, Jin Hee Kim iD, Byoung Kuk Jang iD, Wen-Yen Huang, Hiroshi Aikata iD, Myungsoo Kim, Jung Hyun Kwon iD, Jinbo Yue, Victor Ho Fun Lee iD, Zhaochong Zeng und 1 weitere

Cancers · 13.06.2023 · 15 (12) · 3164

DOI: 10.3390/cancers15123164 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 13.06.2023. Verfasst von Jina Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dong-A research fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Although systemic treatment is the mainstay for advanced hepatocellular carcinoma (HCC), numerous studies have highlighted the added value of local treatment. This study aimed to investigate the clinical efficacy of liver-directed combined radiotherapy (LD combined RT) compared with that of sorafenib, a recommended treatment until recently for locally advanced HCC presenting portal vein tumor thrombosis (PVTT), using a multinational patient cohort. Materials and Methods: We identified patients with HCC presenting PVTT treated with either sorafenib or LD combined RT in 10 tertiary hospitals in Asia from 2005 to 2014. Propensity score matching (PSM) was performed to minimize the imbalance between the two groups. The primary endpoint was overall survival (OS), and the secondary endpoints were progression-free survival (PFS) and treatment-related toxicity.

Results

A total of 1035 patients (675 in the LD combined RT group and 360 in the sorafenib group) were included in this study. After PSM, 305 patients from each group were included in the analysis. At a median follow-up of 22.5 months, the median OS was 10.6 and 4.2 months for the LD combined RT and sorafenib groups, respectively (p < 0.001). The conversion rate to curative surgery was significantly higher (8.5% vs. 1.0%, p < 0.001), while grade ≥ 3 toxicity was fewer (9.2% vs. 16.1%, p < 0.001) in the LD combined RT group.

Conclusions

LD combined RT improved survival outcomes with a higher conversion rate to curative surgery in patients with locally advanced HCC presenting PVTT. Although further prospective studies are warranted, active multimodal local treatment involving radiotherapy is suggested for locally advanced HCC presenting PVTT.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomaportal vein tumor thrombosisprognostic factorsradiotherapysorafenib

Autor:innen und Institutionen

  • Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
  • Department of Radiation Oncology, National Taiwan University Hospital, Taipei 100229, Taiwan.
  • Department of Radiation Oncology, Chonnam National University Hwasun Hospital, Hwasun 58128, Republic of Korea.
  • Department of Radiation Oncology, Keimyung University, Dongsan Hospital, Daegu 42601, Republic of Korea.
  • Department of Internal Medicine, Keimyung University, Dongsan Hospital, Daegu 42601, Republic of Korea.
  • Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114202, Taiwan.

ORCID-Profile: Jina Kim, Jason Chia-Hsien Cheng, Taek-Keun Nam, Jin Hee Kim, Byoung Kuk Jang, Hiroshi Aikata, Jung Hyun Kwon, Victor Ho Fun Lee, Jinsil Seong

Förderung

  • Dong-A research fund

Zitieren

APA

Kim, J., Cheng, J. C., Nam, T. K., Kim, J. H., Jang, B. K., Huang, W. Y., Aikata, H., Kim, M., Kwon, J. H., Yue, J., Lee, V. H. F., Zeng, Z., & Seong, J. (2023). Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers, 15(12), 3164. https://doi.org/10.3390/cancers15123164

Vancouver

Kim J, Cheng JC, Nam TK, Kim JH, Jang BK, Huang WY, et al. Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers. 2023;15(12):3164. doi:10.3390/cancers15123164

BibTeX
@article{Kim2023,
  author = {Kim, Jina and Cheng, Jason Chia-Hsien and Nam, Taek-Keun and Kim, Jin Hee and Jang, Byoung Kuk and Huang, Wen-Yen and Aikata, Hiroshi and Kim, Myungsoo and Kwon, Jung Hyun and Yue, Jinbo and Lee, Victor Ho Fun and Zeng, Zhaochong and Seong, Jinsil},
  title = {Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {3164},
  doi = {10.3390/cancers15123164}
}
Kostenlos starten →